Adoptive immunotherapy for Hodgkin's lymphoma (Q36513566)

14 August 2017

1 reference

title

Adoptive immunotherapy for Hodgkin's lymphoma (English)

1 reference

14 August 2017

1 reference

2

Catherine M Bollard

1 reference

14 August 2017

3

Cliona M Rooney

1 reference

14 August 2017

author name string

Alana A Kennedy-Nasser

series ordinal

1

1 reference

14 August 2017

publication date

1 June 2006

1 reference

International Journal of Hematology

14 August 2017

published in

1 reference

14 August 2017

volume

83

1 reference

14 August 2017

issue

5

1 reference

14 August 2017

page(s)

385-390

1 reference

https://scigraph.springernature.com/pub.10.1532/ijh97.06107

14 August 2017

exact match

0 references

cites work

Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis.

1 reference

12 December 2020

Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes

1 reference

12 December 2020

High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma

1 reference

12 December 2020

Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation

1 reference

12 December 2020

Immune escape mechanisms in Hodgkin's disease

1 reference

12 December 2020

Epstein-Barr virus (EBV)-encoded membrane protein LMP1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B cell-derived homologue.

1 reference

12 December 2020

Interaction between host T cells and Reed-Sternberg cells in Hodgkin lymphomas.

1 reference

12 December 2020

Anti-CD45-mediated cytoreduction to facilitate allogeneic stem cell transplantation

1 reference

12 December 2020

Characteristics of Hodgkin's Lymphoma after Infectious Mononucleosis

1 reference

12 December 2020

Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells.

1 reference

12 December 2020

Graft-versus-lymphoma effect in refractory cutaneous T-cell lymphoma after reduced-intensity HLA-matched sibling allogeneic stem cell transplantation

1 reference

12 December 2020

Epstein-Barr virus-specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin's disease patients: implications for a T-cell-based therapy.

1 reference

12 December 2020

Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells

1 reference

12 December 2020

Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes

1 reference

12 December 2020

The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease

1 reference

12 December 2020

Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells

1 reference

12 December 2020

Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease

1 reference

12 December 2020

Hematopoietic and immunomodulatory effects of lytic CD45 monoclonal antibodies in patients with hematologic malignancy

1 reference

12 December 2020

Functional characterization of EBV-encoded nuclear antigen 1-specific CD4+ helper and regulatory T cells elicited by in vitro peptide stimulation

1 reference

12 December 2020

Interleukin 13: a growth factor in hodgkin lymphoma.

1 reference

12 December 2020

Isolation of Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes that lyse Reed-Sternberg cells: implications for immune-mediated therapy of EBV+ Hodgkin's disease

1 reference

12 December 2020

The role of different subsets of T regulatory cells in controlling autoimmunity

1 reference

12 December 2020

Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease.

1 reference

12 December 2020

B cells under influence: transformation of B cells by Epstein–Barr virus

1 reference

12 December 2020

CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness

1 reference

12 December 2020

Regulatory T cells in autoimmmunity*.

1 reference

12 December 2020

Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data.

1 reference

12 December 2020

Analysis of major histocompatibility complex class I, TAP expression, and LMP2 epitope sequence in Epstein-Barr virus-positive Hodgkin's disease.

1 reference

12 December 2020

Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells

1 reference

12 December 2020

Expression of human tumor-associated antigen RCAS1 in Reed-Sternberg cells in association with Epstein-Barr virus infection: a potential mechanism of immune evasion

1 reference

12 December 2020

Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test

1 reference

12 December 2020

Interleukin-2 secretion by human B lymphocytes occurs as a late event and requires additional stimulation after CD40 cross-linking

1 reference

12 December 2020

Immunization of cancer patients using autologous cancer cells modified by insertion of the gene for tumor necrosis factor

1 reference

12 December 2020

Adapting a transforming growth factor beta-related tumor protection strategy to enhance antitumor immunity.

1 reference

12 December 2020

TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma

1 reference

12 December 2020

Lymphocyte homeostasis

1 reference

12 December 2020

Soluble interleukin-13Ralpha2 decoy receptor inhibits Hodgkin's lymphoma growth in vitro and in vivo.

1 reference

12 December 2020

Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations

1 reference

12 December 2020

Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma

1 reference

12 December 2020

Regulatory T cells: key controllers of immunologic self-tolerance

1 reference

12 December 2020

Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen

1 reference

12 December 2020

HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2.

1 reference

12 December 2020

A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma

1 reference

12 December 2020

Sequence polymorphism in the Epstein-Barr virus latent membrane protein (LMP)-2 gene.

1 reference

12 December 2020

The role of suppressor T cells in regulation of immune responses

1 reference

12 December 2020

Differential regulation of IL-13 and IL-4 production by human CD8+ and CD4+ Th0, Th1 and Th2 T cell clones and EBV-transformed B cells

1 reference

12 December 2020

T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells

1 reference

12 December 2020

A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells

1 reference

12 December 2020

TGFbeta signaling in growth control, cancer, and heritable disorders

1 reference

12 December 2020

A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency.

1 reference

12 December 2020

Dysfunction of monocytes in Hodgkin's disease by excessive production of PGE-2 in long-term remission patients

1 reference

12 December 2020

Increase of regulatory T cells in the peripheral blood of cancer patients.

1 reference

12 December 2020

An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation

1 reference

12 December 2020

Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells

1 reference

12 December 2020

Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells

1 reference

12 December 2020

T-regulatory 1 cells: a novel subset of CD4 T cells with immunoregulatory properties.

1 reference

12 December 2020

Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow Transplantation.

1 reference

12 December 2020

Hodgkin's disease and the acquired immunodeficiency syndrome

1 reference

12 December 2020

Characterization of latent membrane protein 2 specificity in CTL lines from patients with EBV-positive nasopharyngeal carcinoma and lymphoma

1 reference

12 December 2020

Identifiers

DOI

10.1532/IJH97.06107

1 reference

Dimensions Publication ID

14 August 2017

1036169931

0 references

1 reference